Evaluation of orgotein in treatment of locomotor dysfunction in dogs.
D000818:Animals; D001168:Arthritis / Q000188:drug therapy / Q000662:veterinary; D002986:Clinical Trials as Topic; D003300:Copper / Q000008:administration & dosage / Q000627:therapeutic use; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D004341:Drug Evaluation; D007405:Intervertebral Disc Displacement / Q000188:drug therapy / Q000662:veterinary; D008667:Metalloproteins / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D013122:Spinal Diseases / Q000188:drug therapy / Q000662:veterinary*; D013166:Spondylitis / Q000188:drug therapy / Q000662:veterinary; D015032:Zinc / Q000008:administration & dosage / Q000627:therapeutic use
D008667:Metalloproteins; D010919:Placebos; D003300:Copper; D015032:Zinc